ANI Pharmaceuticals: A Growth Stock with Strong Earnings and Cash Flow Growth Prospects

ANI Pharmaceuticals (ANIP) is a growth stock with a favorable Zacks Growth Style Score and a top Zacks Rank. The company's EPS is expected to grow 14% this year, crushing the industry average of 11.3%. Additionally, its cash flow growth rate of 39.3% is higher than the industry average of -4.5%. The company's annualized cash flow growth rate has been 23.1% over the past 3-5 years versus the industry average of 4.8%. These factors make ANIP a great growth pick.